These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 17367211)

  • 21. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
    Goicoechea de Jorge E; Tortajada A; García SP; Gastoldi S; Merinero HM; García-Fernández J; Arjona E; Cao M; Remuzzi G; Noris M; Rodríguez de Córdoba S
    J Am Soc Nephrol; 2018 Jan; 29(1):240-249. PubMed ID: 28993505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study.
    Wu D; Chen J; Ling C; Chen Z; Fan J; Sun Q; Meng Q; Liu X
    Nephron; 2021; 145(4):415-427. PubMed ID: 33873197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor H and CFHR1 polymorphisms associated with atypical Haemolytic Uraemic Syndrome (aHUS) are differently expressed in Tunisian and in Caucasian populations.
    Leban N; Abarrategui-Garrido C; Fariza-Requejo E; Amiñoso-Carbonero C; Pinto S; Chibani JB; Khelil AH; Sánchez-Corral P
    Int J Immunogenet; 2012 Apr; 39(2):110-3. PubMed ID: 22136554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome.
    Eyler SJ; Meyer NC; Zhang Y; Xiao X; Nester CM; Smith RJ
    Pediatr Nephrol; 2013 Nov; 28(11):2221-5. PubMed ID: 23880784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels.
    Reuter M; Caswell CC; Lukomski S; Zipfel PF
    J Biol Chem; 2010 Dec; 285(49):38473-85. PubMed ID: 20855886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of CFHR deletions in Indian women with pregnancy-associated hemolytic uremic syndrome.
    Kandari S; Chakurkar V; Gaikwad S; Agarwal M; Phadke N; Lobo V
    Nephrology (Carlton); 2022 Mar; 27(3):231-237. PubMed ID: 34796567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-factor H antibody and its role in atypical hemolytic uremic syndrome.
    Raina R; Mangat G; Hong G; Shah R; Nair N; Abboud B; Bagga S; Sethi SK
    Front Immunol; 2022; 13():931210. PubMed ID: 36091034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.
    Zhu L; Zhai YL; Wang FM; Hou P; Lv JC; Xu DM; Shi SF; Liu LJ; Yu F; Zhao MH; Novak J; Gharavi AG; Zhang H
    J Am Soc Nephrol; 2015 May; 26(5):1195-204. PubMed ID: 25205734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement factor H related proteins in immune diseases.
    Skerka C; Zipfel PF
    Vaccine; 2008 Dec; 26 Suppl 8():I9-14. PubMed ID: 19388158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome.
    Heinen S; Sanchez-Corral P; Jackson MS; Strain L; Goodship JA; Kemp EJ; Skerka C; Jokiranta TS; Meyers K; Wagner E; Robitaille P; Esparza-Gordillo J; Rodriguez de Cordoba S; Zipfel PF; Goodship TH
    Hum Mutat; 2006 Mar; 27(3):292-3. PubMed ID: 16470555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
    Chaudhary P; Hepgur M; Sarkissian S; Smith RJ; Weitz IC
    Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077
    [No Abstract]   [Full Text] [Related]  

  • 33. Carfilzomib-induced aHUS responds to early eculizumab and may be associated with heterozygous
    Portuguese AJ; Lipe B
    Blood Adv; 2018 Dec; 2(23):3443-3446. PubMed ID: 30518536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.
    Strobel S; Abarrategui-Garrido C; Fariza-Requejo E; Seeberger H; Sánchez-Corral P; Józsi M
    Kidney Int; 2011 Aug; 80(4):397-404. PubMed ID: 21677636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
    J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement Genetic Variants and FH Desialylation in
    Gómez Delgado I; Corvillo F; Nozal P; Arjona E; Madrid Á; Melgosa M; Bravo J; Szilágyi Á; Csuka D; Veszeli N; Prohászka Z; Sánchez-Corral P
    Front Immunol; 2021; 12():641656. PubMed ID: 33777036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent.
    Raychaudhuri S; Ripke S; Li M; Neale BM; Fagerness J; Reynolds R; Sobrin L; Swaroop A; Abecasis G; Seddon JM; Daly MJ
    Nat Genet; 2010 Jul; 42(7):553-5; author reply 555-6. PubMed ID: 20581873
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.
    Maga TK; Meyer NC; Belsha C; Nishimura CJ; Zhang Y; Smith RJ
    Nephrol Dial Transplant; 2011 Feb; 26(2):739-41. PubMed ID: 20974643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.
    Ferrer F; Roldão M; Figueiredo C; Lopes K
    Nephron; 2022; 146(2):185-189. PubMed ID: 34724668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.